Comparison of Moducare versus Wait-and-See approach for histologically proven Low-grade Cervical Intraepithelial Neoplasia (CIN1) (MODUCIN1 TRIAL) – Study protocol

Dimitrios Zouzoulas, Iliana Sofianou, Kimon Chatzistamatiou, Vasilis Theodoulidis, Grigoris Grimbizis, Dimitrios Tsolakidis · 2026

Read Comparison of Moducare versus Wait-and-See approach for histologically proven Low-grade Cervical Intraepithelial Neoplasia (CIN1) (MODUCIN1 TRIAL) – Study protocol by Dimitrios Zouzoulas, Iliana Sofianou, Kimon Chatzistamatiou, Vasilis Theodoulidis, Grigoris Grimbizis, Dimitrios Tsolakidis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353119.txt.

Description

Zouzoulas and colleagues laid out a trial plan in 2026 for early, mild cell changes on the cervix. Most such changes clear on their own, so standard care is watching and waiting. The trial tests whether a plant-based supplement that supports immunity helps more changes clear within six months.

Patients with newly confirmed mild changes will be assigned by chance to supplement or watchful waiting alone. Clearance rates will then be compared between the two groups. People with any past cervical changes or pelvic cancer are excluded. If the supplement helps, some patients could avoid long anxious monitoring, though results must come before any such claim is made.

Catalog record

CREATORDimitrios Zouzoulas, Iliana Sofianou, Kimon Chatzistamatiou, Vasilis Theodoulidis, Grigoris Grimbizis, Dimitrios Tsolakidis
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23381
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0353119

Browse the full library · About the Tower of Babel